Summary: Cigna Healthcare modified its plantar fasciitis treatments coverage policy (policy 0097), effective May 16, 2026. Here's what billing teams need to know before that date.
Cigna Healthcare updated its long-standing plantar fasciitis policy — formally titled "Plantar Fasciitis Treatments" under policy identifier 0097 — with changes taking effect May 16, 2026. The full payer document does not publish specific CPT or HCPCS codes in the data available at this time. That gap matters, and we'll address it directly below. If your practice treats plantar fasciitis and bills Cigna, read this before the effective date arrives.
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Plantar Fasciitis Treatments (0097) |
| Policy Code | 0097 |
| Change Type | Modified |
| Effective Date | May 16, 2026 |
| Impact Level | High |
| Specialties Affected | Podiatry, orthopedic surgery, physical therapy, sports medicine, pain management |
| Key Action | Pull the full 0097 policy document from Cigna's portal and audit your active plantar fasciitis claims before May 16, 2026 |
Cigna Plantar Fasciitis Coverage Criteria and Medical Necessity Requirements 2026
Plantar fasciitis is one of the most common musculoskeletal diagnoses in outpatient podiatry and orthopedics. Cigna's 0097 policy governs which treatments it considers medically necessary, which it covers conditionally, and which it designates as experimental or investigational. A modification to this coverage policy — even a subtle one — can shift reimbursement outcomes on a high-volume diagnosis.
Cigna's standard framework for plantar fasciitis coverage has historically required documented conservative treatment failure before authorizing more advanced interventions. That means your chart documentation needs to show the patient tried and failed conservative care — things like physical therapy, orthotics, and anti-inflammatory medication — before Cigna will consider procedures like extracorporeal shock wave therapy (ESWT) or platelet-rich plasma (PRP) injections as medically necessary.
Because the specific revised criteria from this May 2026 update are not published in the available policy data, your team cannot rely on prior authorization submissions built around the old criteria. Pull the updated 0097 document directly from Cigna's coverage policy portal before May 16, 2026. The exact wording of medical necessity thresholds — duration of conservative care, required documentation, and specialist involvement — may have shifted.
What we know from Cigna's general approach to plantar fasciitis billing: prior authorization is typically required for procedures beyond conservative management. If your practice has been submitting without prior auth on certain treatment codes, verify that position against the updated 0097 policy now.
Cigna Plantar Fasciitis Exclusions and Non-Covered Indications
Cigna's plantar fasciitis coverage policy has historically excluded or designated as experimental several treatments that providers commonly offer. The specific exclusions in the May 2026 revision are not detailed in the available policy data. However, the categories worth watching — based on Cigna's prior 0097 versions — include the following.
Platelet-rich plasma (PRP) injections for plantar fasciitis have frequently appeared as not covered or experimental under Cigna policy. If your practice offers PRP and bills Cigna, this is where your claim denial risk is highest. Check the updated 0097 document for any change in PRP's coverage status — a modification in either direction changes your financial exposure.
Dry needling and certain ultrasound-guided injection techniques have also had inconsistent coverage status across Cigna policy updates. Any treatment your team bills that sits at the edge of Cigna's covered-versus-experimental line should be re-verified against the May 16, 2026 version of this policy.
If you're not sure how your current treatment mix maps to the updated 0097 criteria, talk to your compliance officer before the effective date.
Coverage Indications at a Glance
The policy data available for this update does not include a detailed, indication-level breakdown of covered versus non-covered treatments under the revised 0097. The table below reflects the general framework Cigna has applied to plantar fasciitis treatments historically. Verify each row against the full updated policy document before May 16, 2026.
| Indication / Treatment | Status | Notes |
|---|---|---|
| Conservative care (orthotics, physical therapy, NSAIDs) | Covered | Typically first-line; documentation of trial required |
| Extracorporeal shock wave therapy (ESWT) | Conditionally covered | Usually requires documented failure of conservative care (often 3–6 months); prior authorization typically required |
| Corticosteroid injections | Covered with documentation | Medical necessity documentation required; frequency limits may apply |
| Platelet-rich plasma (PRP) injections | Historically not covered / experimental | High claim denial risk; verify status in updated 0097 |
| Dry needling | Status uncertain | Has varied across Cigna policy versions; verify against updated 0097 |
| Ultrasound-guided injections | Conditionally covered | Coverage may depend on the primary procedure being billed |
| Surgical intervention (fasciotomy) | Covered when criteria met | Requires documented failure of all conservative and non-surgical options |
Important: These rows reflect general Cigna policy history, not the specific text of the May 2026 revision. Do not treat this table as a substitute for reading the updated 0097 document.
Cigna Plantar Fasciitis Billing Guidelines and Action Items 2026
The modification to Cigna's 0097 policy creates real work for your billing team before May 16, 2026. Here are the steps to take now.
| # | Action Item |
|---|---|
| 1 | Pull the updated 0097 policy document from Cigna's coverage policy portal today. Don't wait until May 15. You need time to compare the new criteria against your current workflow and fix anything that's out of alignment. |
| 2 | Audit your active prior authorization queue for plantar fasciitis cases. Any prior auth submitted under the old criteria may need to be re-evaluated. If Cigna changed the required duration of conservative care or added new documentation requirements, auth requests that haven't been approved yet may need supporting documentation added before the effective date. |
| 3 | Review your charge capture process for any plantar fasciitis treatment codes you bill regularly. If the policy added new codes to the experimental designation — or removed them — your charge capture needs to reflect that change before May 16, 2026. Billing a code Cigna now considers experimental guarantees a claim denial. |
| 4 | Update your clinical documentation templates. Cigna's medical necessity requirements for plantar fasciitis treatments depend heavily on documented conservative care duration, prior treatment history, and clinical findings. If the 0097 revision changed the minimum required documentation, your templates need to match. |
| 5 | Communicate the change to your treating providers before May 16. Your podiatrists, orthopedic surgeons, and physical therapists need to know if anything in the coverage criteria shifted. A physician who doesn't know the policy changed will keep ordering treatments under the old assumptions — and your billing team will deal with the denials. |
| 6 | Check whether prior authorization requirements changed for any specific treatment types. Cigna sometimes modifies which procedures trigger prior auth as part of a broader policy update. A procedure that didn't require prior auth under the old 0097 may require it now. Running a claim without required prior auth is one of the most avoidable reasons for denial. |
| 7 | If you bill a high volume of ESWT or PRP for plantar fasciitis under Cigna, talk to your compliance officer now. These are the highest-risk codes in this policy area. A coverage status change on either one of them has direct revenue implications. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Plantar Fasciitis Treatments Under Policy 0097
The policy data available for Cigna's May 2026 0097 modification does not include a published list of specific CPT, HCPCS, or ICD-10 codes. We do not fabricate codes. Publishing invented codes here would be worse than publishing none — your billing team would act on wrong information.
What this means for you: go to the source. Pull the full 0097 policy from Cigna's coverage policy portal and extract the code list directly from that document. The codes governing plantar fasciitis billing — including procedure codes for ESWT, corticosteroid injections, PRP, physical therapy modalities, and surgical intervention — will be listed there with their associated coverage status.
In the meantime, the codes your team should be verifying against the updated policy are those in the procedure families commonly associated with plantar fasciitis treatment. Physical therapy modalities, injection procedures, shock wave therapy, and plantar fascia surgical codes all fall within the scope of this coverage policy. Confirm each one against the May 16, 2026 version before billing.
When the full code list becomes available through Cigna's portal or a policy update notification, we'll update this post. If you're a PayerPolicy subscriber, you'll get that update automatically.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.